The Soluble Type 2 Insulin-like Growth Factor (IGF-II) Receptor Reduces Organ Size by IGF-II-mediated and IGF-II-independent Mechanisms

This publication has 27 references indexed in Scilit:

• Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
  Proceedings of the National Academy of Sciences, 1997
• Growth-Promoting Interaction of IGF-II with the Insulin Receptor during Mouse Embryonic Development
  Developmental Biology, 1997
• Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors
  Physiological Reviews, 1996
• Mouse Mutants Lacking the Type 2 IGF Receptor (IGF2R) Are Rescued from Perinatal Lethality inIgf2andIgf1rNull Backgrounds
  Developmental Biology, 1996
• Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition
  Biochemical Society Transactions, 1996
• Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
• Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality.
  Genes & Development, 1994
• Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene
  Nature, 1994
• STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
  Annual Review of Biochemistry, 1992
• Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.
  Proceedings of the National Academy of Sciences, 1991